11329 Results

People

  1. Brennan
    Brennan
  2. Scher
    Scher
  3. Reuter
    Reuter
  4. Motzer
    Motzer
  5. Zelefsky
    Zelefsky
  6. Gonen
    Gonen
  7. Jarnagin
    Jarnagin
  8. Herr
    Herr
  9. Vickers
    Vickers
  10. Shah
    Shah

Groups

  1. Department of Medicine (3805)
  2. Surgery (2846)
  3. Solid Tumor Oncology Division (2184)
  4. Survivorship Research (1958)
  5. GSK Faculty (1620)
  6. Sloan Kettering Institute Faculty (1560)
  7. Population Sciences Research Program (1504)
  8. Epidemiology and Biostatistics (1357)
  9. Department of Pathology and Laboratory Medicine (1348)
  10. Center for Hematologic Malignancies (1215)
  1. "male"
Formats
  1. Journal Article (10594)
  2. Review (211)
  3. Conference Paper (176)
  4. Research Letter (148)
  5. Editorial (84)
  6. Correspondence (44)
  7. Guidelines (39)
  8. Miscellaneous (16)
  9. Meeting Abstract (11)
  10. Book Section (5)
  11. Book Whole (1)
Groups
  1. Department of Medicine (3805)
  2. Surgery (2846)
  3. Solid Tumor Oncology Division (2184)
  4. Survivorship Research (1958)
  5. GSK Faculty (1620)
  6. Sloan Kettering Institute Faculty (1560)

More Groups

People
  1. Murray Brennan (366)
  2. Howard Scher (260)
  3. Victor Reuter (198)
  4. Robert Motzer (188)
  5. Michael Zelefsky (171)
  6. Mithat Gonen (170)

More People

Years
  1. 2025 (460)
  2. 2024 (1175)
  3. 2023 (708)
  4. 2022 (547)
  5. 2021 (283)
  6. 2020 (562)

More Years

Publications
  1. Cancer (520)
  2. Journal of Clinical Oncology (442)
  3. International Journal of Radiation Oncology, Biology, Physics (264)
  4. Clinical Cancer Research (211)
  5. Annals of Surgical Oncology (203)
  6. Journal of Urology (196)

More Publications

Publishers
  1. Elsevier Inc. (1379)
  2. Elsevier Science, Inc. (1046)
  3. Wiley Blackwell (923)
  4. Springer (777)
  5. Lippincott Williams & Wilkins (776)
  6. American Society of Clinical Oncology (529)

More Publishers

Results (11329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I dose-escalation study of the HIF-2 alpha inhibitor DFF332 in patients with advanced clear-cell renal cell carcinoma
    Journal Article

    Pal, S. K.; Bernard-Tessier, A.; Grell, P.; Gao, X.; Kotecha, R. R.; Picus, J.; de Braud, F.; Takahashi, S.; Wong, A.; Suárez, C.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Phase I trial of selinexor in pediatric recurrent/refractory solid and CNS tumors (ADVL1414): A Children’s Oncology Group phase I consortium trial
    Journal Article

    Green, A. L.; Minard, C. G.; Liu, X.; Safgren, S. L.; Pinkney, K.; Harris, L.; Link, G.; DeSisto, J.; Voss, S.; Nelson, M. D.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Recommended clinical context and patient context data elements for liquid biopsy data submitted to data repositories and data commons
    Guidelines

    Grossman, R. L.; Vinson, J.; Bain, E.; Bisselou, K.; Chandan, S.; Compton, C.; Hu, J.; Johann, D. J.; Jones, F.; Jones, G.; more...
    CTS-Clinical and Translational Science (2025)

    Fulltext@MSK | Save
  • Glioma grade and mortality in relation to sequence variation in the mitochondrial genome
    Journal Article

    Peeri, N. C.; Teer, J. K.; Thompson, Z. J.; Nabors, L. B.; Brooks, M.; Sologon, C. M.; Williams, S. L.; Egan, K. M.
    Cancer Genetics (2025)

    Fulltext@MSK | Save
  • Association of inherited genetic variants with multiple primary melanoma
    Journal Article

    Gibbs, D. C.; Small, B. M.; Autuori, I.; Leong, S. F.; Ali, E.; Kenney, J.; Luo, L.; Kanetsky, P. A.; Busam, K. J.; Cust, A. E.; more...
    Cancer Epidemiology Biomarkers and Prevention (2025)

    Fulltext@MSK | Save
  • High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
    Journal Article

    Sharifi, M. N.; Sperger, J. M.; Taylor, A. K.; Tippins, K. E.; Reese, S. R.; Carreno, V.; Kaufmann, K. R.; Chang, A. H.; Nunamaker, L. A.; Linebarger, C.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Pharmacokinetic profile of novel reduced-dose Danziten(TM) (nilotinib tablets) versus Tasigna® (nilotinib capsules): In vivo bioequivalence and population pharmacokinetic analysis
    Journal Article

    Mauro, M.; Radich, J.; Jain, P.; Sequeira, D.; Bellanti, F.; Douer, D.
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • Disparities in receipt of palliative-intent treatment among disaggregated Hispanic populations with breast, lung, and prostate cancer in the United States
    Journal Article

    Garg, S. K.; Kohli, K.; Garg, I. K.; Garg, Y. K.; Nguyen, L. G.; Nguyen, I. S.; Feliciano, E. J. G.; Baez, Y. A.; Mahal, B. A.; Iyengar, P.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Assessing AML-based risk criteria in patients with accelerated/blastphase MPN treated with less-intensive therapy
    Research Letter

    Shaw, R.; Yoon, J. J.; Johnston, H.; Davidson, M. B.; Siddon, A. J.; Shallis, R. M.; Chen, E. C.; Burkart, M.; Oh, T. S.; Iyer, S. G.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save